Similarly, Harmine [33, 34], which is a TWIST1 inhibitor through its degradation at the protein level (Fig. 2g), could dramatically block the effect of overexpressing AR on VM formation of RCC cells (Fig. 2h–i). This evidence concerns the gene AR and renal cell carcinoma.